- Home
- CCEL vs TACT Comparison
CCEL vs TACT Comparison
Compare CCEL & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- TACT
- Stock Information
- Founded
- CCEL 1989
- TACT 1996
- Country
- CCEL United States
- TACT United States
- Employees
- CCEL N/A
- TACT N/A
- Industry
- CCEL Managed Health Care
- TACT Computer peripheral equipment
- Sector
- CCEL Health Care
- TACT Technology
- Exchange
- CCEL Nasdaq
- TACT Nasdaq
- Market Cap
- CCEL 39.9M
- TACT 35.7M
- IPO Year
- CCEL 1997
- TACT 1996
- Fundamental
- Price
- CCEL $4.83
- TACT $3.85
- Analyst Decision
- CCEL Strong Buy
- TACT Strong Buy
- Analyst Count
- CCEL 1
- TACT 1
- Target Price
- CCEL $8.50
- TACT $5.00
- AVG Volume (30 Days)
- CCEL 13.2K
- TACT 14.5K
- Earning Date
- CCEL 07-22-2025
- TACT 08-07-2025
- Dividend Yield
- CCEL 20.62%
- TACT N/A
- EPS Growth
- CCEL N/A
- TACT N/A
- EPS
- CCEL 0.01
- TACT N/A
- Revenue
- CCEL $32,102,750.00
- TACT $45,750,000.00
- Revenue This Year
- CCEL $2.49
- TACT $14.81
- Revenue Next Year
- CCEL $0.95
- TACT N/A
- P/E Ratio
- CCEL $301.41
- TACT N/A
- Revenue Growth
- CCEL 2.33
- TACT N/A
- 52 Week Low
- CCEL $4.75
- TACT $3.12
- 52 Week High
- CCEL $9.43
- TACT $5.11
- Technical
- Relative Strength Index (RSI)
- CCEL 40.85
- TACT 59.80
- Support Level
- CCEL $4.80
- TACT $3.49
- Resistance Level
- CCEL $6.35
- TACT $3.83
- Average True Range (ATR)
- CCEL 0.26
- TACT 0.22
- MACD
- CCEL -0.03
- TACT 0.03
- Stochastic Oscillator
- CCEL 2.08
- TACT 72.22
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.